Skip to main content
Top
Published in: International Journal of Diabetes in Developing Countries 3/2023

15-05-2023 | Care | Editorial

Emerging health care technologies in diabetes: is it the way forward?

Author: Rajeev Chawla

Published in: International Journal of Diabetes in Developing Countries | Issue 3/2023

Login to get access

Excerpt

The last almost 3 years have been a turning point of sorts for humankind. The COVID 19 pandemic stopped everything in its tracks and drastically changed almost all aspects of our lives. One such paradigm change has been in healthcare delivery, with technology coming to the rescue of many people whose only access to their healthcare providers was through different tech modalities -bringing telemedicine centre-stage. Doctor consultations changed from physical consultations in doctor clinics to audio-visual consultations in the virtual clinic bridging the physical distance, separating the two and bringing them face to face in a virtual world. Data shows a significant increase in use of telemedicine, not only in the developed world but also in the developing countries like India [1]. …
Literature
2.
go back to reference Verma R, Bhardwaj S, Lathia T, Kalra S. Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days. IJDDC. 2023;43(3). Verma R, Bhardwaj S, Lathia T, Kalra S. Personalized glycemic response led digital therapeutics program improves time in range in a period of 14 days. IJDDC. 2023;43(3).
3.
go back to reference Chawla R, Jaggi S, Gupta A, Bantwal G, Patil S. Clinical utility of a digital therapeutic intervention in Indian patients with type 2 diabetes mellitus: a 12-week, prospective, single-arm, intervention study. JMIR. 2022. Chawla R, Jaggi S, Gupta A, Bantwal G, Patil S. Clinical utility of a digital therapeutic intervention in Indian patients with type 2 diabetes mellitus: a 12-week, prospective, single-arm, intervention study. JMIR. 2022.
4.
go back to reference Zhang J, Liu X, Wei L, Zeng Q, Lin K. Telemedicine with advanced communication technology in management of type 2 diabetes mellitus: a network meta-analysis. IJDDC. 2023;43(3). Zhang J, Liu X, Wei L, Zeng Q, Lin K. Telemedicine with advanced communication technology in management of type 2 diabetes mellitus: a network meta-analysis. IJDDC. 2023;43(3).
5.
go back to reference Chawla R, Chawla S, Jaggi S, Chawla A, Kumar R. Diabetes care during COVID-19 pandemic using a telehealth approach: abstract #1042697. Endocr Pract. 2021;27:S24-S71. Chawla R, Chawla S, Jaggi S, Chawla A, Kumar R. Diabetes care during COVID-19 pandemic using a telehealth approach: abstract #1042697. Endocr Pract. 2021;27:S24-S71.
6.
go back to reference Bassi A, Arfin S, John O, Praveen D, Arora V, Kalra OP, Madhu SV, Jha V. Innovative mobile- health led participatory approach to comprehensive screening and treatment of diabetes (IMPACT diabetes): rationale, design and baseline characteristics. IJDDC. 2023;43(3). Bassi A, Arfin S, John O, Praveen D, Arora V, Kalra OP, Madhu SV, Jha V. Innovative mobile- health led participatory approach to comprehensive screening and treatment of diabetes (IMPACT diabetes): rationale, design and baseline characteristics. IJDDC. 2023;43(3).
Metadata
Title
Emerging health care technologies in diabetes: is it the way forward?
Author
Rajeev Chawla
Publication date
15-05-2023
Publisher
Springer India
Published in
International Journal of Diabetes in Developing Countries / Issue 3/2023
Print ISSN: 0973-3930
Electronic ISSN: 1998-3832
DOI
https://doi.org/10.1007/s13410-023-01210-7

Other articles of this Issue 3/2023

International Journal of Diabetes in Developing Countries 3/2023 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine